Christian Klaus Hebenstreit

Biotx.ai is a German company that has developed a causal AI technology that mimics clinical trials in human genetic data. The company is based in Potsdam, Germany, and the CEO of the company is Klinger Jörn. The company has used this technology to develop two drugs that are now in clinical development with a high probability of success. Biotx.ai is now making this technology available to biotech and pharma companies. The company is the first to apply causal modelling in drug development at scale, which allows for fast predictions of clinical success with huge statistical power. Biotx.ai has enabled clients to secure funding, explain the biology of their drugs, and improve the design of their clinical trials.